Emerging treatments in Castleman disease – a critical appraisal of siltuximab
Jean L Koff, Sagar Lonial Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA Abstract: Castleman disease (CD) is a rare, heterogeneous lymphoproliferative disorder for which no standard of care currently exists. Evidence that the pathophysiology of...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2016
|
| Subjects: | |
| Online Access: | https://doaj.org/article/96ec89b0400a4c8dad3c61409a5a9c31 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|